Evidence map›Paper›PMID 26259589›Full record

ArticleParasites & vectors2015

Engaging scientists: An online survey exploring the experience of innovative biotechnological approaches to controlling vector-borne diseases.

Christophe Boëte, Uli Beisel, Luísa Reis Castro, Nicolas Césard, R Guy Reeves

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 4 countries.

Christophe BoëteUMR_D 190 Emergence des Pathologies Virales, Aix Marseille Université, IRD (Institut de Recherche pour le Développement), EHESP (Ecole des Hautes Etudes en Santé Publique), 27 Bd Jean Moulin, 13385, Marseille, Cedex 5, France. cboete@gmail.com.
Uli BeiselCulture and Technology in Africa, Faculty V: Cultural Studies, Universität Bayreuth, Bayreuth, Germany. uli.beisel@gmail.com.
Luísa Reis CastroHistory, Anthropology, and Science, Technology, and Society (HASTS) MIT, 77 Massachusetts Avenue, Cambridge, MA, 02139, USA. luisarc@mit.edu.
Nicolas CésardCNRS-MNHN, UMR 7206 Eco-Anthropologie et Ethnobiologie, Dept Hommes, natures et sociétés, Musée de l'Homme 17 place Trocadéro 75016, Paris, France. ncesard@orange.fr.
R Guy ReevesDepartment of Evolutionary Genetics, Max Planck Institute for Evolutionary Biology August-Thienemannstrasse 2, 24306, Plön, Germany. reeves@evolbio.mpg.de.
Institut de Recherche pour le Développement · FRKyoto University · JPMassachusetts Institute of Technology · USMax Planck Institute for Evolutionary Biology · DEUniversity of Bayreuth · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPioneering technologies (e.g., nanotechnology, synthetic biology or climate engineering) are often associated with potential new risks and uncertainties that can become sources of controversy. The communication of information during their development and open exchanges between stakeholders is generally considered a key issue in their acceptance. While the attitudes of the public to novel technologies have been widely considered there has been relatively little investigation of the perceptions and awareness of scientists working on human or animal diseases transmitted by arthropods.

methodsConsequently, we conducted a global survey on 1889 scientists working on aspects of vector-borne diseases, exploring, under the light of a variety of demographic and professional factors, their knowledge and awareness of an emerging biotechnology that has the potential to revolutionize the control of pest insect populations.

resultsDespite extensive media coverage of key developments (including releases of manipulated mosquitoes into human communities) this has in only one instance resulted in scientist awareness exceeding 50% on a national or regional scale. We document that awareness of pioneering releases significantly relied on private communication sources that were not equally accessible to scientists from countries with endemic vector-borne diseases (dengue and malaria). In addition, we provide quantitative analysis of the perceptions and knowledge of specific biotechnological approaches to controlling vector-borne disease, which are likely to impact the way in which scientists around the world engage in the debate about their value.

conclusionsOur results indicate that there is scope to strengthen already effective methods of communication, in addition to a strong demand by scientists (expressed by 79.9% of respondents) to develop new, creative modes of public engagement.

Indexed as

BiotechnologyAwarenessElectronic MailFemaleHumansInfection ControlKnowledgeLaboratory PersonnelMaleSurveys and QuestionnairesWorkforce

Identifiers

PMID26259589
PMCPMC4530488
OpenAlexW2104915061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.